Published in Proc Natl Acad Sci U S A on October 01, 1974
An enzymatic assay reveals that proteins destined for the apical or basolateral domains of an epithelial cell line share the same late Golgi compartments. EMBO J (1985) 2.78
A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78
Glycosylation of vesicular stomatitis virus glycoprotein in virus-infected HeLa cells. J Virol (1976) 2.06
Synthesis and glycosylation in vitro of glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.95
Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature. J Virol (1979) 1.93
Growth of enveloped RNA viruses in a line of chinese hamster ovary cells with deficient N-acetylglucosaminyltransferase activity. J Virol (1975) 1.71
Purification and composition of the proteins from Sindbis virus grown in chick and BHK cells. J Virol (1976) 1.61
Carbohydrate structure of Sindbis virus glycoprotein E2 from virus grown in hamster and chicken cells. J Virol (1979) 1.59
Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells. J Virol (1985) 1.56
Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50
Sindbis virus glycoproteins: effect of the host cell on the oligosaccharides. J Virol (1975) 1.46
Correlation of glycosylation forms with position in amino acid sequence. J Cell Biol (1983) 1.44
Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J Virol (2010) 1.41
Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus. J Virol (1976) 1.40
Polylactosaminoglycan modification of a small integral membrane glycoprotein, influenza B virus NB. Mol Cell Biol (1988) 1.18
Oligosaccharide chains of avian RNA tumor virus glycoproteins contain heterogeneous oligomannosyl cores. J Virol (1979) 1.06
Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. J Virol (1990) 1.05
Glycopeptides of murine leukemia viruses. I. Comparison of two ecotropic viruses. J Virol (1979) 0.92
Virus-dependent glycosylation. J Virol (1975) 0.92
Expression of the Saccharomyces cerevisiae glycoprotein invertase in mouse fibroblasts: glycosylation, secretion, and enzymatic activity. Proc Natl Acad Sci U S A (1987) 0.91
Expression of intracisternal A-particle-related retroviral element-encoded envelope proteins detected in cell lines. J Virol (1992) 0.87
Insensitivity of a ricin-resistant mutant of Chinese hamster ovary cells to fusion induced by Newcastle disease virus. J Virol (1979) 0.86
Restricted replication of two alphaviruses in ricin-resistant mouse L cells with altered glycosyltransferase activities. J Virol (1979) 0.83
Post-translational modifications of hepatitis C viral proteins and their biological significance. World J Gastroenterol (2013) 0.78
Separation of cyanogen bromide-cleaved peptides of the vesicular stomatitis virus glycoprotein and analysis of their carbohydrate content. J Virol (1980) 0.78
Hazelhurst-vesicular-stomatitis-virus G and Sindbis-virus E1 glycoproteins undergo similar host-cell-dependent variation in oligosaccharide processing. Biochem J (1985) 0.75
Isolation and characterization of mouse FM3A cell mutants which are devoid of Newcastle disease virus receptors. J Virol (1989) 0.75
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
Protein synthesis in vesicular stomatitis virus-infected HeLa cells. Virology (1970) 5.14
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol (1970) 4.54
The determination of carbohydrate in biological materials by gas-liquid chromatography. Methods Biochem Anal (1971) 3.20
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
The development and structure of vesicular stomatitis virus. Virology (1962) 2.44
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
The structure of the glycopeptide of human gamma G myeloma proteins. J Biol Chem (1971) 1.63
Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45
Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci U S A (1970) 1.45
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus. Virology (1974) 1.42
Vesicular stomatitis virus maturation sites in six different host cells. J Gen Virol (1970) 1.41
Studies on fetuin, a glycoprotein of fetal serum. II. Nature of the carbohydrate units. J Biol Chem (1962) 1.32
Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins. Biochemistry (1970) 1.22
Glycosylation of the A1 protein from myelin by a polypeptide N-acetylgalactosaminyltransferase. Identification of the receptor sequence. J Biol Chem (1971) 0.99
RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci U S A (1968) 5.64
Basic concepts in RNA virus evolution. FASEB J (1996) 3.35
Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol (1999) 2.78
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry (1976) 2.69
Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A (1995) 2.60
Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. J Virol (1986) 2.41
Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv Virus Res (1991) 2.38
Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36
Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase. Proc Natl Acad Sci U S A (1974) 2.34
Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30
Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 2.29
Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus. Virology (1986) 2.29
Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J Mol Biol (1999) 2.28
Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene (1992) 2.20
Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus. Virology (1972) 2.18
Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J Virol (1995) 2.18
Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell (1984) 2.13
RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol (1990) 2.12
Subclonal components of consensus fitness in an RNA virus clone. J Virol (1994) 2.09
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus. Cell (1979) 2.04
High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol (1989) 2.04
Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98
Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol (1989) 1.95
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J Virol (1990) 1.87
Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J Virol (1994) 1.86
Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells. J Virol (1995) 1.84
Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus. Nat New Biol (1973) 1.83
Sequence of a RNA templated by the 3'-OH RNA terminus of defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 1.80
Synthesis and cleavage of enterovirus polypeptides in mammalian cells. J Virol (1970) 1.73
Factors involved in the generation and replication of rhabdovirus defective T particles. J Virol (1976) 1.72
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
Membrane and nonmembrane proteins of mammalian cells. Synthesis, turnover, and size distribution. Biochemistry (1970) 1.64
Influenza virus effects on cell membrane proteins. Science (1970) 1.62
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A (1992) 1.60
Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol (1999) 1.60
Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol (1978) 1.57
Virus-induced interference in heterologously infected HeLa cells. J Virol (1972) 1.57
Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology (1975) 1.54
Role of defective interfering particles of Sendai virus in persistent infections. Virology (1979) 1.52
Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50
Coupled in vitro transcription and translation of vesicular stomatitis virus messenger RNA. Proc Natl Acad Sci U S A (1975) 1.48
High multiplicities of infection favor rapid and random evolution of vesicular stomatitis virus. Virology (1982) 1.47
Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol (1997) 1.45
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus. Virology (1974) 1.42
Virus-directed protein synthesis in different animal and human cells. Science (1968) 1.41
RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus. Virology (1974) 1.41
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus? J Virol (1980) 1.34
Properties of DI particle resistant mutants of vesicular stomatitis virus isolated from persistent infections and from undiluted passages. Cell (1983) 1.31
Diversity within natural populations of eastern equine encephalomyelitis virus. Virology (1993) 1.27
Studies on the in vitro transcription and translation of vesicular stomatitis virus mRNA. Virology (1976) 1.26
Vesicular stomatitis virus mutants resistant to defective-interfering particles accumulate stable 5'-terminal and fewer 3'-terminal mutations in a stepwise manner. J Virol (1984) 1.25
Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers. J Virol (1987) 1.23
Proteinase activity in purified animal viruses. Biochem Biophys Res Commun (1972) 1.21
Denatured DNA as a direct template for in vitro protein synthesis. Proc Natl Acad Sci U S A (1965) 1.21
Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Drug Res (1997) 1.21
Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun (1973) 1.21
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
Generation of defective interfering particles in picornaviruses. Virology (1980) 1.15
Evolution of fitness in experimental populations of vesicular stomatitis virus. Genetics (1996) 1.11
Natural selection of mutants of vesicular stomatitis virus by cultured cells of Drosophila melanogaster. J Gen Virol (1973) 1.11
Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents. Genet Eng (N Y) (1992) 1.10
Chromatographic differences between tyrosyl transfer RNA from different mammalian cells. Proc Natl Acad Sci U S A (1967) 1.10
Reproducible nonlinear population dynamics and critical points during replicative competitions of RNA virus quasispecies. J Mol Biol (1996) 1.08
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Oligosaccharide chains of avian RNA tumor virus glycoproteins contain heterogeneous oligomannosyl cores. J Virol (1979) 1.06
Multiple protein components of mammalian cell membranes. Proc Natl Acad Sci U S A (1968) 1.05
Viruses isolated from cells persistently infected with vesicular stomatitis virus show altered interactions with defective interfering particles. J Virol (1980) 1.05
Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection. J Gen Virol (1986) 1.02
Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med (1997) 1.01
Human fibroblasts prefer mannose over glucose as a source of mannose for N-glycosylation. Evidence for the functional importance of transported mannose. J Biol Chem (1997) 1.01
Transcribing complexes in cells infected by vesicular stomatitis virus and rabies virus. J Virol (1974) 1.00
Analysis of virus replication in ageing human fibroblast cultures. Nature (1973) 1.00
Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini. J Virol (1979) 0.99
THE MAMMALIAN CELL-VIRUS RELATIONSHIP : V. SUSCEPTIBILITY AND RESISTANCE OF CELLS IN VITRO TO INFECTION BY COXSACKIE A9 VIRUS. J Exp Med (1960) 0.97
Preparation and characterization of two monoclonal antibodies against different epitopes in Escherichia coli ribosomal protein L7/L12. J Biol Chem (1985) 0.97
Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo. J Gen Virol (1980) 0.95
An immunohistochemical characterization of rhesus monkey respiratory secretions using monoclonal antibodies. Am Rev Respir Dis (1985) 0.95
A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. Bull World Health Organ (1975) 0.95
The nucleotide sequence of the 5' terminus of vesicular stomatitis virus RNA. Nucleic Acids Res (1979) 0.94
Stimulation of protein synthesis in vitro by partially degraded ribosomal ribonucleic acid and transfer ribonucleic acid. Biochemistry (1966) 0.93
Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance. J Virol (1996) 0.92
Rapid viral quasispecies evolution: implications for vaccine and drug strategies. Mol Med Today (1995) 0.92
Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology (1998) 0.90
Vesicular stomatitis virus and its defective interfering particles exhibit in vitro transcriptional and replicative competition for purified L-NS polymerase molecules. Virology (1989) 0.89
Analysis of viral and defective-interfering nucleocapsids in acute and persistent infection by rhabdoviruses. J Gen Virol (1982) 0.88
Size distrbution of polypeptide chains in cells. Nature (1970) 0.88
Viral genome synthesis in BHK 21 cells persistently infected with Sendai virus. Virology (1980) 0.88
Genome RNA terminus conservation and diversity among vesiculoviruses. J Virol (1987) 0.87
Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology (1974) 0.87
Structure and origin of a novel class of defective interfering particle of vesicular stomatitis virus. Nucleic Acids Res (1984) 0.87
Single-stranded DNA as a template for in vitro protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 0.87